Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Chinese medicine Qinbudan
in Patients Receiving Standard Combination Therapy for Retreatment Pulmonary Tuberculosis.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Collaborator:
Ministry of Science and Technology of the People´s Republic of China